Publications by authors named "Parija Patel"

Claim this Profile
C
Clinically meaningful improvements in patient-reported outcomes in mitapivat-treated patients with pyruvate kinase deficiency.
Kevin H M Kuo, Rachael F Grace, Eduard J van Beers, Wilma Barcellini, Andreas Glenthøj, Parija Patel

Am J Hematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycolytic activity and in vitro effect of the pyruvate kinase activator AG-946 in red blood cells from low-risk myelodysplastic syndromes patients: A proof-of-concept study.
Bruno Fattizzo, Cristina Vercellati, Anna Marcello, Parija Patel, Megan Wind-Rotolo

Am J Hematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency.
Eduard J van Beers, Hanny Al-Samkari, Rachael F Grace, Wilma Barcellini, Andreas Glenthøj, Parija Patel

Blood Adv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sutimlimab provides clinically meaningful improvements in patient-reported outcomes in patients with cold agglutinin disease: Results from the randomised, placebo-controlled, Phase 3 CADENZA study.
Alexander Röth, Catherine M Broome, Wilma Barcellini, Bernd Jilma, Quentin A Hill, Parija Patel

Eur J Haematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: Analysis of an integrated claim-clinical cohort in the United States.
Catherine M Broome, Naushin Hooda, Jun Su, Xiaohui Jiang, Gina Nicholson, Parija Patel

PLoS One· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial.
Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini, Shirley D'Sa, Bernd Jilma, Parija Patel

Blood· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results.
Alexander Roth, Wilma Barcellini, Shirley D'Sa, Yoshitaka Miyakawa, Catherine M Broome, Parija Patel

Haematologica· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement-mediated hemolysis persists year round in patients with cold agglutinin disease.
Alexander Röth, Jon Fryzek, Xiaohui Jiang, Heidi Reichert, Parija Patel

Transfusion· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis